Magnetization transfer imaging

Neuroimaging Clinics of North America

Volumn 10, Issue 4, 2000, Pages 771-788

  Van Buchem, M A ^a   Tofts, P S ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE MARKER; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW;

BRAIN; DISABILITY EVALUATION; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; SENSITIVITY AND SPECIFICITY;

EID: 0034449576     PISSN: 10525149     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (109)

1. Demyelinating diseases
2. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis
3. Studies on the pathogenesis of multiple sclerosis. Participation of lysosomes on demyelination in the central nervous system white matter outside plaques
4. Standardising magnetisation transfer ratio measurements between MR scanners from different manufacturers
5. An interleaved sequence for accurate and reproducible clinical measurement of magnetization transfer ratio
6. Sensitivity of enhanced MR in multiple sclerosis: Effects of contrast dose and magnetization transfer contrast
7. A multicenter measurement of magnetization transfer ratio in normal white matter
8. Optic neuritis: Imaging with magnetization transfer
9. Enhanced and unenhanced MR with magnetization transfer in multiple sclerosis
10. Pathological correlates of magnetization transfer imaging abnormalities in animal models and humans with multiple sclerosis
11. Magnetisation transfer ratios of contrast-enhancing and nonenhancing lesions in multiple sclerosis
12. A multiparametric MRI study of frontal lobe dementia in multiple sclerosis
13. Statistical analysis of MTR histograms in multiple sclerosis
14. Magnetization transfer study of HIV encephalitis and progressive multifocal leukoencephalopathy
15. Lysolecithin-induced demyelination in primates: Preliminary in vivo study with MR and magnetization transfer
16. Early structural changes in acute MS lesions assessed by serial magnetization transfer studies
17. Experimental allergic encephalomyelitis and multiple sclerosis: Lesion characterization with magnetization transfer imaging
18. Cranial tissues: Appearance at gadolinium-enhanced and nonenhanced MR imaging with magnetization transfer contrast
19. Magnetization transfer imaging to monitor the evolution of individual multiple sclerosis lesions
20. A conventional and magnetization transfer MRI study of the cervical cord in patients with MS
21. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis
22. Triple dose of gadolinium-DTPA and delayed MRI in patients with benign multiple sclerosis
23. Magnetization transfer ratio changes in a symptomatic lesion of a patient at presentation with possible multiple sclerosis
24. Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis
25. Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI
26. Magnetization transfer ratios of multiple sclerosis lesions with variable durations of enhancement
27. A one year study of new lesions in multiple sclerosis using monthly gadolinium-enhanced MRI: Correlations with changes of T2 and magnetization transfer lesion loads
28. Magnetization transfer imaging of patients with definite MS and negative conventional MRI
29. MRI and magnetization transfer imaging changes in the brain and spinal cord of patients with Devic's neuromyelitis optica
30. Short-term evolution of individual enhancing MS lesions studied with magnetization transfer imaging
31. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis
32. Magnetization transfer ratios in multiple sclerosis lesions enhancing after different doses of gadolinium
33. Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis
34. Cerebral white matter: Technical development and clinical applications of effective magnetization transfer (MT) power concepts for high-power, thin section, quantitative MT examinations
35. Magnetization transfer in neuroimaging
36. Magnetization transfer and multicomponent T2 relaxation measurements with histopathologic correlation in an experimental model of MS
37. Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis
38. MRI lesion volume measurement in multiple sclerosis and its correlation with disability: A comparison of fast fluid-attenuated inversion recovery (fFLAIR) and spin echo sequences
39. Clinical utility of a new contrast option from magnetization transfer contrast
40. A serial study of new MS lesions and the white matter from which they arise
41. Magnetization transfer study of remyelination in a toxic demyelination model
42. Correlation of magnetic resonance imaging parameters with clinical disability in multiple sclerosis: A preliminary study
43. Patterns of cognitive impairment in relapsing-remitting and chronic progressive multiple sclerosis
44. Perspectives on multiple sclerosis
45. Quantitative interpretation of magnetization transfer
46. Magnetization transfer effects in MR-detected multiple sclerosis lesions: Comparison with gadolinium-enhanced spin-echo images and nonenhanced T1-weighted images
47. Correlation of spectroscopy and magnetization transfer imaging in the evaluation of demyelinating lesions and normal appearing white matter in multiple sclerosis
48. Quantitative analysis of magnetization transfer images of the brain: Effect of closed head injury, age and sex on white matter
49. Correlations between clinical and MRI involvement in multile sclerosis: Assessment using T1, T2 and MT histograms
50. Heterogeneity of blood-brain barrier changes in multiple sclerosis: An MRI study with gadolinium-DTPA enhancement
51. Serial magnetisation transfer ratios in gadolinium-enhancing lesions in multiple sclerosis
52. MR of Wallerian degeneration in the feline visual system: Characterization by magnetization transfer rate with histopathologic correlation
53. Microscopic disease in normal-appearing white matter on conventional images in patients with multiple sclerosis: Assessment with magnetization transfer measurements
54. Characterization of multiple sclerosis plaques with T1-weighted MR and quantitative a magnetization transfer
55. Magnetization transfer ratio of the spinal cord in multiple sclerosis: Relation to atrophy and neurologic disability
56. Combined effects of magnetization transfer and gadolinium in cranial MR imaging and MR angiography
57. The pathological evolution of multiple sclerosis
58. The physical basis of magnetization transfer imaging
59. Improved detection of enhancing and nonenhancing lesions of multiple sclerosis with magnetization transfer
60. Magnetization transfer MR of the normal adult brain
61. Central nervous system tumor, infection, and infarction: Detection with gadolinium-enhanced magnetization transfer MR imaging
62. Contrast-enhanced magnetization transfer MR of the brain: Importance of precontrast images
63. Differences between relapsing-remitting and chronic progressive multiple sclerosis as determined with quantitative MR imaging
64. Multiparameter NMR imaging of the spinal cord post mortem in multiple sclerosis
65. Characterization of differences between multiple sclerosis and mai brain: A global magnetization transfer application
66. Serial analysis of magnetization-transfer histograms and expanded disability status scale scores in patients with relapsing-remitting multiple sclerosis
67. Correlating magnetic resonance imaging markers of axonal injury and demyelination in motor impairment secondary to stroke and multiple sclerosis
68. Multiple sclerosis lesions: Relationship between MR enhancement pattern and magnetization transfer effect
69. Comparison of T2 lesion volume and magnetization transfer ratio histogram analysis and of atrophy and measures of lesion burden in patients with multiple sclerosis
70. Combined magnetization transfer and proton spectroscopic imaging in the assessment of pathologic brain lesions in multiple sclerosis
71. Comparison of continuous wave theory to pulsed multicentre MT data
72. Neuropsychology of multiple sclerosis: A critical review
73. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction
74. Magnetization transfer imaging to monitor clinical trials in multiple sclerosis
75. Serial monthly magnetization transfer histogram analysis in multiple sclerosis patients: Correlation with bulk white matter lesion load
76. Long term changes of MT-derived measures from patients with relapsing-remitting and secondary-progressive multiple sclerosis
77. Brain MRI correlates of magnetization transfer imaging metrics in patients with multiple sclerosis
78. Intra-observer reproducibility in measuring new putative MR markers of demyelination and axonal loss in multiple sclerosis: A comparison with T2-weighted images
79. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis
80. Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis
81. Evolution of multiple sclerosis lesions on serial contrast-enhanced T1-weighted and magnetization-transfer MR images
82. Magnetisation transfer ratio measurements of the brain depend on region of interest position within headcoil
83. Magnetisation transfer ratio measurement in the cervical spinal cord - A preliminary study in multiple sclerosis
84. Decreased magnetization transfer ratio due to demyelination: A case of central pontine myelinolysis
85. Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging
86. Serial magnetization transfer imaging to characterize the early evolution of new MS lesions
87. Magnetisation transfer ratio of normal brain white matter: A normative database spanning four decades of life
88. Quantitative imaging of magnetization transfer parameters in-vivo using MRI
89. The effect of demyelination on T1, T2 and magnetization transfer in white matter
90. Magnetisation transfer ratios and transverse magnetisation decay curves in optic neuritis: Correlation with clinical findings and electrophysiology
91. Standardisation and optimisation of magnetic resonance techniques for multicenter studies
92. Magnetization transfer: A potential method to determine the age of multiple sclerosis lesions
93. A magnetization transfer histogram study of normal-appearing brain tissue in MS
94. Axonal transaction in the lesions of multiple sclerosis
95. Magnetization transfer: Applications in neuroradiology
96. Magnetization transfer histogram methodology: Its clinical and neuropsychological correlates
97. Correlation of volumetric magnetization transfer imaging with clinical data in MS
98. Quantitative volumetric magnetization transfer analysis in multiple sclerosis: Estimation of macroscopic and microscopic disease burden
99. Global estimation of disease burden in multiple sclerosis based on magnetization transfer
100. Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability
101. Histopathologic correlate of MTR and hypointense signal intensity on T1 SE in multiple sclerosis lesions. A direct postmortem study
102. MR outcome parameters in multiple sclerosis: Comparison of surface-based thresholding segmentation and magnetization transfer ratio histographic analysis in relation to disability
103. Single-dose gadolinium with magnetization transfer versus triple-dose gadolinium in the MR detection of multiple sclerosis lesions
104. Comparison of four potential MR parameters for severe tissue destruction in multiple sclerosis lesions
105. Patterns of lesion development in multiple sclerosis: Longitudinal observations with T1-weighted spin-echo and magnetization transfer
106. Correlating MRI and clinical disease activity in multiple sclerosis: Relevance of hypointense lesions on short TR/short TE (T1-weighted) spin-echo images
107. A comparison between magnetization transfer ratios and myelin water percentages in normals and multiple sclerosis patients
108. Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo
109. Magnetization transfer imaging: Practical aspects and clinical applications